Back to all studies
CompletedNCT01926912

Usage of Paliperidone Palmitate in people with Schizophrenia in a Hospital Setting

This study is completed. It focuses on schizophrenia and currently lists study information in Belgium, Bulgaria, Denmark, Germany, Greece, Israel, Kazakhstan, and Russian Federation.

SchizophreniaDrugOver 18 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Usage of Paliperidone Palmitate may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Usage of Paliperidone Palmitate, attend study visits with the research team. The registry lists locations in Belgium, in Bulgaria, and in Denmark.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateMay 2013
Recruitment status
Completed
Enrollment listed in the registry
371
Sponsor
Janssen-Cilag International NV
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
Belgium, Bulgaria, Denmark, ...
Age range
Over 18 Years
Official registry ID
NCT01926912
Official title
HOSPItal Use of Paliperidone Palmitate - A Prospective Non-Interventional Study

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Belgium · 3 sites
  • Diest
    Diest
    Site status: Not listed — confirm with the team
  • Saint-Servais
    Saint-Servais
    Site status: Not listed — confirm with the team
  • Tournai
    Tournai
    Site status: Not listed — confirm with the team
Bulgaria · 6 sites
  • Pazardzhik
    Pazardzhik
    Site status: Not listed — confirm with the team
  • Rousse
    Rousse
    Site status: Not listed — confirm with the team
  • Sofia
    Sofia
    Site status: Not listed — confirm with the team
  • Stara Zagora
    Stara Zagora
    Site status: Not listed — confirm with the team
  • Targovishte
    Targovishte
    Site status: Not listed — confirm with the team
  • Vratsa
    Vratsa
    Site status: Not listed — confirm with the team
Denmark · 2 sites
  • Elsinore
    Elsinore
    Site status: Not listed — confirm with the team
  • København S
    København S
    Site status: Not listed — confirm with the team
Germany · 9 sites
  • Berlin
    Berlin
    Site status: Not listed — confirm with the team
  • Chemnitz
    Chemnitz
    Site status: Not listed — confirm with the team
  • Dresden
    Dresden
    Site status: Not listed — confirm with the team
  • Greifswald
    Greifswald
    Site status: Not listed — confirm with the team
  • Hamburg
    Hamburg
    Site status: Not listed — confirm with the team
  • Hennigsdorf
    Hennigsdorf
    Site status: Not listed — confirm with the team
  • Neuruppin
    Neuruppin
    Site status: Not listed — confirm with the team
  • Pfaffenhofen
    Pfaffenhofen
    Site status: Not listed — confirm with the team
  • Sachsen
    Sachsen
    Site status: Not listed — confirm with the team
Greece · 4 sites
  • Heraklion Crete
    Heraklion Crete
    Site status: Not listed — confirm with the team
  • Ioannina
    Ioannina
    Site status: Not listed — confirm with the team
  • Katerini Pieria
    Katerini Pieria
    Site status: Not listed — confirm with the team
  • Thessaloniki
    Thessaloniki
    Site status: Not listed — confirm with the team
Israel · 2 sites
  • Bat Yam
    Bat Yam
    Site status: Not listed — confirm with the team
  • Tel Litwinsky
    Tel Litwinsky
    Site status: Not listed — confirm with the team
Kazakhstan · 5 sites
  • Almaty
    Almaty
    Site status: Not listed — confirm with the team
  • Astana
    Astana
    Site status: Not listed — confirm with the team
  • Kyzylorda
    Kyzylorda
    Site status: Not listed — confirm with the team
  • Taraz
    Taraz
    Site status: Not listed — confirm with the team
  • Ust-Kamenogorsk
    Ust-Kamenogorsk
    Site status: Not listed — confirm with the team
Russia · 8 sites
  • Chelyabinsk
    Chelyabinsk
    Site status: Not listed — confirm with the team
  • Moscow
    Moscow
    Site status: Not listed — confirm with the team
  • Nizhny Novgorod
    Nizhny Novgorod
    Site status: Not listed — confirm with the team
  • Omsk
    Omsk
    Site status: Not listed — confirm with the team
  • Orenburg, Staritsa Village
    Orenburg, Staritsa Village
    Site status: Not listed — confirm with the team
  • Saint Petersburg
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Tula Region
    Tula Region
    Site status: Not listed — confirm with the team
  • Yaroslavl
    Yaroslavl
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01926912. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving No intervention. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with schizophrenia; age range: Over 18 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Janssen-Cilag International NV, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me